407 related articles for article (PubMed ID: 31980686)
21. Probing the binding affinity of plasma proteins adsorbed on Au nanoparticles.
Zhang X; Zhang J; Zhang F; Yu S
Nanoscale; 2017 Apr; 9(14):4787-4792. PubMed ID: 28345718
[TBL] [Abstract][Full Text] [Related]
22. Poly (N-vinylpyrrolidone) modification mitigates plasma protein corona formation on phosphomolybdate-based nanoparticles.
Yu Y; Ghalandari B; Shen G; Wang L; Liu X; Wang A; Li S; Xie H; Ding X
J Nanobiotechnology; 2021 Dec; 19(1):445. PubMed ID: 34949196
[TBL] [Abstract][Full Text] [Related]
23. Impact of Surface-Engineered ZnO Nanoparticles on Protein Corona Configuration and Their Interactions With Biological System.
Srivastav AK; Dhiman N; Khan H; Srivastav AK; Yadav SK; Prakash J; Arjaria N; Singh D; Yadav S; Patnaik S; Kumar M
J Pharm Sci; 2019 May; 108(5):1872-1889. PubMed ID: 30615879
[TBL] [Abstract][Full Text] [Related]
24. Understanding the nanoparticle-protein corona complexes using computational and experimental methods.
Kharazian B; Hadipour NL; Ejtehadi MR
Int J Biochem Cell Biol; 2016 Jun; 75():162-74. PubMed ID: 26873405
[TBL] [Abstract][Full Text] [Related]
25. Tuning liposome composition to modulate corona formation in human serum and cellular uptake.
Yang K; Mesquita B; Horvatovich P; Salvati A
Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780
[TBL] [Abstract][Full Text] [Related]
26. Nanoparticles-cell association predicted by protein corona fingerprints.
Palchetti S; Digiacomo L; Pozzi D; Peruzzi G; Micarelli E; Mahmoudi M; Caracciolo G
Nanoscale; 2016 Jul; 8(25):12755-63. PubMed ID: 27279572
[TBL] [Abstract][Full Text] [Related]
27. Effects of Nanoparticle Electrostatics and Protein-Protein Interactions on Corona Formation: Conformation and Hydrodynamics.
Lee H
Small; 2020 Mar; 16(10):e1906598. PubMed ID: 32022403
[TBL] [Abstract][Full Text] [Related]
28. How Corona Formation Impacts Nanomaterials as Drug Carriers.
Gupta MN; Roy I
Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
[TBL] [Abstract][Full Text] [Related]
29. The protein corona on nanoparticles as viewed from a nanoparticle-sizing perspective.
Wang H; Lin Y; Nienhaus K; Nienhaus GU
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1500. PubMed ID: 29071798
[TBL] [Abstract][Full Text] [Related]
30. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
Liu N; Tang M; Ding J
Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
[TBL] [Abstract][Full Text] [Related]
31. In Situ Characterization of the Protein Corona of Nanoparticles In Vitro and In Vivo.
Latreille PL; Rabanel JM; Le Goas M; Salimi S; Arlt J; Patten SA; Ramassamy C; Hildgen P; Martinez VA; Banquy X
Adv Mater; 2022 Sep; 34(38):e2203354. PubMed ID: 35901787
[TBL] [Abstract][Full Text] [Related]
32. The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
Nanoscale; 2019 May; 11(18):8760-8775. PubMed ID: 30793730
[TBL] [Abstract][Full Text] [Related]
33. Plasma protein adsorption and biological identity of systemically administered nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
Nanomedicine (Lond); 2017 Sep; 12(17):2113-2135. PubMed ID: 28805542
[TBL] [Abstract][Full Text] [Related]
34. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
Moraru C; Mincea M; Menghiu G; Ostafe V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
[TBL] [Abstract][Full Text] [Related]
35. A nanoinformatics decision support tool for the virtual screening of gold nanoparticle cellular association using protein corona fingerprints.
Afantitis A; Melagraki G; Tsoumanis A; Valsami-Jones E; Lynch I
Nanotoxicology; 2018 Dec; 12(10):1148-1165. PubMed ID: 30182778
[TBL] [Abstract][Full Text] [Related]
36. Beyond the protein corona - lipids matter for biological response of nanocarriers.
Müller J; Prozeller D; Ghazaryan A; Kokkinopoulou M; Mailänder V; Morsbach S; Landfester K
Acta Biomater; 2018 Apr; 71():420-431. PubMed ID: 29524674
[TBL] [Abstract][Full Text] [Related]
37. Protein-Nanoparticle Interaction: Corona Formation and Conformational Changes in Proteins on Nanoparticles.
Park SJ
Int J Nanomedicine; 2020; 15():5783-5802. PubMed ID: 32821101
[TBL] [Abstract][Full Text] [Related]
38. Protein Corona in Response to Flow: Effect on Protein Concentration and Structure.
Jayaram DT; Pustulka SM; Mannino RG; Lam WA; Payne CK
Biophys J; 2018 Jul; 115(2):209-216. PubMed ID: 29650368
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona.
Tang H; Zhang Y; Yang T; Wang C; Zhu Y; Qiu L; Liu J; Song Y; Zhou L; Zhang J; Wong YK; Liu Y; Xu C; Wang H; Wang J
Nat Nanotechnol; 2023 Sep; 18(9):1067-1077. PubMed ID: 37537273
[TBL] [Abstract][Full Text] [Related]
40. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
